AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9481962 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine with lidocaine
Number of subjects: 39
Study 9481962 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine without lidocaine
Number of subjects: 39
Study 1782954 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin withdrawal (sudden or gradual)
Number of subjects: 47
Study 1782954 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin withdrawal
Number of subjects: 47
Study 6784849 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical mastectomy followed by adjuvant chemotherapy (CMF: cyclophosphamide, methotrexate, fluorouracil)
Number of subjects: 386
Study 6784849 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 386
Study 30326768 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Consultation Offices for Seniors (CHCO) intervention
Number of subjects: 403
Study 30326768 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 403
Study 30791944 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin-enhanced motivational interviewing group therapy (MIGT)
Number of subjects: 50
Study 30791944 — intervention group
Group type: COMPARATOR
Intervention: Placebo-enhanced motivational interviewing group therapy (MIGT)
Number of subjects: 50
Study 27707943 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observation training (watching video clips demonstrating four-staged ambulation training)
Number of subjects: 25
Study 27707943 — intervention group
Group type: COMPARATOR
Intervention: Control group (watching video clips of different landscape pictures)
Number of subjects: 25
Study 26024940 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Tranexamic Acid (TA)
Number of subjects: 17
Study 26024940 — intervention group
Group type: COMPARATOR
Intervention: Combined Oral Contraceptives (COC)
Number of subjects: 17
Study 24418284 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dynamic CT with iterative reconstruction (ASIR) at 100 kV, 40% ASIR, 480 mg I/kg contrast
Number of subjects: 113
Study 24418284 — intervention group
Group type: COMPARATOR
Intervention: Conventional dynamic CT without ASIR at 120 kV, 0% ASIR, 600 mg I/kg contrast
Number of subjects: 113
Study 22559867 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily
Number of subjects: 20
Study 22559867 — intervention group
Group type: COMPARATOR
Intervention: 0.005% latanoprost once every other day
Number of subjects: 20
Study 19952754 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 48
Study 19952754 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 48
Study 19113994 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised program of nurse home visiting
Number of subjects: 208
Study 16134183 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrothermal bipolar vessel sealing system (group B)
Number of subjects: 184
Study 16134183 — intervention group
Group type: COMPARATOR
Intervention: Classic suture ligation technique (group A)
Number of subjects: 184
Study 12208638 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS at 130% of the individual motor threshold (MT) applied continuously over the right PFC for 20 minutes
Number of subjects: 8
Study 12208638 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 8
Study 10505156 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin 100 mg/m2, bleomycin 15 U/m2, and 5-fluorouracil 1000 mg/m2/day for 1-3 cycles followed by radiotherapy.
Number of subjects: 33
Study 10505156 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy with methotrexate 50 mg/m2 (1-6 weekly injections) followed by radiotherapy.
Number of subjects: 33
Study 10505156 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with radical surgery followed by radiotherapy.
Number of subjects: 33
Study 10505156 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin, bleomycin, and 5-fluorouracil followed by radiotherapy.
Number of subjects: 33
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Innocuous vibration
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Innocuous transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Innocuous warming of skin
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious heating of skin
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious chemical skin stimulation (using mustard oil)
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Mildly noxious constant current transdermal electrical stimulation
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Innocuous stimuli applied prior to histamine or mustard oil
Number of subjects: 0
Study 8867255 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious stimuli applied 2 min after histamine or mustard oil challenge
Number of subjects: 0
Study 1533167 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with 0.375% bupivacaine plus sufentanil, 1:200,000 (5 micrograms/mL) and intraoperative GA with midazolam/N2O
Number of subjects: 20
Study 1533167 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 20
Study 1533167 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 20
Study 4083810 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional method of preoperative skin preparation (routine shaving with cetrimide and chlorhexidine in alcohol)
Number of subjects: 716
Study 4083810 — intervention group
Group type: COMPARATOR
Intervention: Alternate method without preoperative shaving
Number of subjects: 716
Study 31452950 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicolored dental restoration
Number of subjects: 30
Study 31452950 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 30188013 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (20 minutes a day for 6 weeks)
Number of subjects: 91
Study 30188013 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 91
Study 23661044 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival bevacizumab (2.5 mg/0.1 mL)
Number of subjects: 42
Study 23661044 — intervention group
Group type: COMPARATOR
Intervention: Topical MMC (0.2 mg/mL for 3 min)
Number of subjects: 42
Study 25154822 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus cisplatin-radiation
Number of subjects: 891
Study 25154822 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-radiation alone
Number of subjects: 891
Study 25154822 — intervention group
Group type: EXPERIMENTAL
Intervention: p16-positive oropharyngeal carcinoma (OPC)
Number of subjects: 891
Study 25154822 — intervention group
Group type: EXPERIMENTAL
Intervention: p16-negative oropharyngeal carcinoma (OPC)
Number of subjects: 891
Study 21963316 — intervention group
Group type: EXPERIMENTAL
Intervention: Online parent-based intervention
Number of subjects: 558
Study 21963316 — intervention group
Group type: COMPARATOR
Intervention: e-newsletter control group
Number of subjects: 558
Study 19420103 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse mid-dilution haemodiafiltration (MD-HDF)
Number of subjects: 15
Study 19420103 — intervention group
Group type: COMPARATOR
Intervention: Standard mid-dilution haemodiafiltration (MD-HDF)
Number of subjects: 15
Study 17228349 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol margarine (2 g of plant sterols daily)
Number of subjects: 21
Study 17228349 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanol-enriched margarine (2 g of stanols daily)
Number of subjects: 21
Study 17228349 — intervention group
Group type: COMPARATOR
Intervention: Control margarine
Number of subjects: 21
Study 15342889 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral skills training program
Number of subjects: 45
Study 15342889 — intervention group
Group type: EXPERIMENTAL
Intervention: Eddie Eagle GunSafe Program
Number of subjects: 45
Study 15342889 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ training
Number of subjects: 45
Study 15342889 — intervention group
Group type: COMPARATOR
Intervention: Education-based learning materials
Number of subjects: 45
Study 11718517 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg melatonin
Number of subjects: 13
Study 11718517 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg zopiclone
Number of subjects: 13
Study 11718517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8112538 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic findings of giardiasis duodenitis
Number of subjects: 60
Study 8112538 — intervention group
Group type: COMPARATOR
Intervention: Normal duodenoscopy
Number of subjects: 60
Study 3003715 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine (RRV) MMU 18006, 10^5 plaque-forming units
Number of subjects: 27
Study 3003715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 29577919 — intervention group
Group type: EXPERIMENTAL
Intervention: BSA × sPGA
Number of subjects: 3866
Study 29577919 — intervention group
Group type: EXPERIMENTAL
Intervention: BSA
Number of subjects: 3866
Study 27607861 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin challenge test (5 international units/500 mL oxytocin Ringer lactate infused at a rate of 12 mL/h, doubled every 10 minutes until three uterine contractions per 10‐minute interval)
Number of subjects: 78
Study 27607861 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (saline)
Number of subjects: 78
Study 26652987 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg perindopril arginine salt
Number of subjects: 524
Study 26652987 — intervention group
Group type: COMPARATOR
Intervention: 4 mg perindopril tert-butylamine salt
Number of subjects: 524
Study 23440570 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir (DRV/r) 800/100 mg
Number of subjects: 689
Study 23440570 — intervention group
Group type: COMPARATOR
Intervention: lopinavir/ritonavir (LPV/r) 800/200 mg
Number of subjects: 689
Study 20543746 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) protocol: 15-s intervals at 100% of peak power output (PPO) with 15-s passive recovery intervals.
Number of subjects: 20
Study 20543746 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MICE) protocol: isocaloric exercise corresponding to 70% of PPO.
Number of subjects: 20
Study 20543746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIIE and MICE protocols.
Number of subjects: 20
Study 18959704 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal welding system tonsillectomy (TWS)
Number of subjects: 50
Study 18959704 — intervention group
Group type: COMPARATOR
Intervention: Conventional 'cold' extracapsular dissection complete tonsillectomy
Number of subjects: 50
Study 17699280 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor plus candesartan (2 to 12 mg/d)
Number of subjects: 90
Study 17699280 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitor
Number of subjects: 90
Study 14577825 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit Information (EI) provided to stroke participants
Number of subjects: 20
Study 14577825 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit Information (EI) provided to control participants
Number of subjects: 20
Study 14577825 — intervention group
Group type: COMPARATOR
Intervention: No Explicit Information (No-EI) for stroke participants
Number of subjects: 20
Study 14577825 — intervention group
Group type: COMPARATOR
Intervention: No Explicit Information (No-EI) for control participants
Number of subjects: 20
Study 10624998 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 0 ng/mL
Number of subjects: 50
Study 10624998 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 2 ng/mL
Number of subjects: 50
Study 10624998 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 4 ng/mL
Number of subjects: 50
Study 10624998 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 8 ng/mL
Number of subjects: 50
Study 10624998 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 16 ng/mL
Number of subjects: 50
Study 9181203 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco purchase attempts by underage confederates at all outlets
Number of subjects: 14
Study 9181203 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter outlets
Number of subjects: 14
Study 9181203 — intervention group
Group type: EXPERIMENTAL
Intervention: Store factors influencing purchase success
Number of subjects: 14
Study 9181203 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers purchasing their own tobacco
Number of subjects: 14
Study 1389512 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose prochlorperazine 0.8 mg/kg intravenously
Number of subjects: 0
Study 1389512 — intervention group
Group type: COMPARATOR
Intervention: High-dose metoclopramide 2 mg/kg intravenously
Number of subjects: 0
Study 3101865 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg twice daily
Number of subjects: 301
Study 3101865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 29398425 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic group
Number of subjects: 20
Study 29398425 — intervention group
Group type: COMPARATOR
Intervention: Simulation group
Number of subjects: 20
Study 27383293 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg/week IVIG
Number of subjects: 109
Study 27383293 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g/kg/week IVIG
Number of subjects: 109
Study 27383293 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 109
Study 25355723 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT + TMZ
Number of subjects: 100
Study 25355723 — intervention group
Group type: COMPARATOR
Intervention: WBRT
Number of subjects: 100
Study 23252878 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg vortioxetine
Number of subjects: 611
Study 23252878 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg vortioxetine
Number of subjects: 611
Study 23252878 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg
Number of subjects: 611
Study 23252878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 611
Study 21335506 — intervention group
Group type: EXPERIMENTAL
Intervention: RCS+AR
Number of subjects: 0
Study 21335506 — intervention group
Group type: EXPERIMENTAL
Intervention: RCS
Number of subjects: 0
Study 21335506 — intervention group
Group type: COMPARATOR
Intervention: Read Naturally (comparison condition)
Number of subjects: 0
Study 18930603 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 116
Study 18930603 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 116
Study 17269614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2950
Study 15472494 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 57
Study 15472494 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg (titrated to 10 mg after 4 weeks)
Number of subjects: 57
Study 15472494 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg (titrated to 5 mg and 10 mg after 1 and 3 weeks)
Number of subjects: 57
Study 11751708 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasudil (3.2, 6.4, 12.8, and 25.6 microg/min)
Number of subjects: 26
Study 11751708 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (0.4, 0.8, 1.6, and 3.2 microg/min)
Number of subjects: 26
Study 11751708 — intervention group
Group type: COMPARATOR
Intervention: Resting forearm vascular resistance
Number of subjects: 26
Study 9443137 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal information
Number of subjects: 147
Study 9443137 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphically supported information
Number of subjects: 147
Study 9443137 — intervention group
Group type: EXPERIMENTAL
Intervention: Video colposcopy
Number of subjects: 147
Study 9443137 — intervention group
Group type: COMPARATOR
Intervention: No standardized information (control condition)
Number of subjects: 147
Study 8420241 — intervention group
Group type: EXPERIMENTAL
Intervention: Anisoylated plasminogen streptokinase activator complex (APSAC)
Number of subjects: 45
Study 8420241 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 45
Study 3526534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) monotherapy without steroids
Number of subjects: 0
Study 3526534 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunosuppression with azathioprin and prednisone (Aza/P)
Number of subjects: 0
Study 29415846 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-dependence pharmacotherapy (methadone, buprenorphine, oral naltrexone)
Number of subjects: 8736
Study 29415846 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naltrexone
Number of subjects: 8736
Study 29415846 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-dependence pharmacotherapy group
Number of subjects: 8736
Study 29415846 — intervention group
Group type: COMPARATOR
Intervention: Outpatient substance abuse treatment without opioid-dependence pharmacotherapy
Number of subjects: 8736
Study 27569387 — intervention group
Group type: EXPERIMENTAL
Intervention: Endeavor zotarolimus‐eluting stenting (E‐ZES)
Number of subjects: 8709
Study 27569387 — intervention group
Group type: COMPARATOR
Intervention: Cypher sirolimus‐eluting stenting (C‐SES)
Number of subjects: 8709
Study 24571282 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily text messages for 6 months
Number of subjects: 659
Study 24571282 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 659
Study 22087047 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Charge Session
Number of subjects: 172
Study 22087047 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD of four inspirational stories
Number of subjects: 172
Study 21110437 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 250-1000 mg ademetionine for 28 days
Number of subjects: 33
Study 21110437 — intervention group
Group type: COMPARATOR
Intervention: Yinzhihuang Granule and Compound Glycyrrhizin Injection (control group)
Number of subjects: 33
Study 17237966 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Matching (EM) question format
Number of subjects: 13
Study 17237966 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Answer (SA) question format
Number of subjects: 13
Study 17237966 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetico-deductive reasoning
Number of subjects: 13
Study 17237966 — intervention group
Group type: EXPERIMENTAL
Intervention: Straightforward task
Number of subjects: 13
Study 17237966 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult task
Number of subjects: 13
Study 15918812 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 382
Study 12814852 — intervention group
Group type: EXPERIMENTAL
Intervention: venlafaxine XR (75 or 150 mg/d)
Number of subjects: 540
Study 12814852 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (15 mg/d)
Number of subjects: 540
Study 12814852 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 540
Study 12814852 — intervention group
Group type: EXPERIMENTAL
Intervention: venlafaxine XR (75 or 150 mg/d) from verum-sensitive centres
Number of subjects: 540
Study 10480771 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe personal stressors (SPS) reported in the month before HbA1c measurement
Number of subjects: 55
Study 10480771 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive life events reported during the same time period
Number of subjects: 55
Study 8933997 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxamine (vasoconstrictor)
Number of subjects: 6
Study 8933997 — intervention group
Group type: COMPARATOR
Intervention: Strain gauge method
Number of subjects: 6
Study 8933997 — intervention group
Group type: COMPARATOR
Intervention: Finapres (finger arterial blood pressure monitor)
Number of subjects: 6
Study 1653140 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg sumatriptan
Number of subjects: 235
Study 1653140 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg sumatriptan (second dose at 1 hour)
Number of subjects: 235
Study 1653140 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 235
Study 1653140 — intervention group
Group type: COMPARATOR
Intervention: placebo (second dose at 1 hour)
Number of subjects: 235
Study 1653140 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan
Number of subjects: 235
Study 1653140 — intervention group
Group type: COMPARATOR
Intervention: sumatriptan and placebo
Number of subjects: 235
Study 6411497 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate 25 mg/day
Number of subjects: 46
Study 6411497 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate 50 mg/day
Number of subjects: 46
Study 6411497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 6411497 — intervention group
Group type: COMPARATOR
Intervention: Mesterolone (100 mg/day)
Number of subjects: 46
Study 6411497 — intervention group
Group type: COMPARATOR
Intervention: Pentoxifylline (1200 mg/day)
Number of subjects: 46
Study 6411497 — intervention group
Group type: COMPARATOR
Intervention: Testosterone rebound therapy (100 or 250 mg on alternate weeks)
Number of subjects: 46
Study 29781580 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation (NMES)
Number of subjects: 59
Study 29781580 — intervention group
Group type: COMPARATOR
Intervention: Volitional Resistance Training
Number of subjects: 59
Study 28877115 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer C (high levels of glycerin)
Number of subjects: 25
Study 28877115 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer E (high levels of glycerin)
Number of subjects: 25
Study 27240397 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute cocoa consumption
Number of subjects: 33